Predict your next investment

SOFTWARE (NON-INTERNET/MOBILE) | Healthcare Software
crixlabs.com

See what CB Insights has to offer

Stage

Seed | Dead

Total Raised

$100K

Last Raised

$100K

About CRIXlabs

CRIXlabs is a life science software company which predicts outcomes for biodistribution and half-life for a wide range of nanotherapeutics. The company's NuSilico software has the ability to aid researchers in optimizing key characteristics to ensure their particles have a greater chance of reaching their targets. The CRIXlabs team brings expertise in software, nanotechnology, materials, product development, business development, and commercialization.

CRIXlabs Headquarter Location

615 Grant Avenue Third Floor

San Francisco, California, 94108,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CRIXlabs Patents

CRIXlabs has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/1/2014

10/6/2015

Drug discovery, Pharmacokinetics, Ion channels, Medicinal chemistry, Rare diseases

Grant

Application Date

8/1/2014

Grant Date

10/6/2015

Title

Related Topics

Drug discovery, Pharmacokinetics, Ion channels, Medicinal chemistry, Rare diseases

Status

Grant

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.